Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;195(6):3653-3670.
doi: 10.1007/s12010-023-04439-4. Epub 2023 Mar 24.

Drugs for COVID-19 Treatment: A New Challenge

Pratik Talukder  1 , Arunima Saha  2 , Sohini Roy  2 , Gargi Ghosh  2 , Debshikha Dutta Roy  2 , Snejuti Barua  2
Affiliations
Review

Drugs for COVID-19 Treatment: A New Challenge

Pratik Talukder et al. Appl Biochem Biotechnol. 2023 Jun.

Abstract

COVID-19 infection is a new disease and our knowledge is limited; day in and day out more and more interesting yet diverse observations are reported by the different research groups from different corners of the world. So, there is an urgent requirement of the invention of some effective and efficient drugs that can carry out the end of the deadly viral infection. Throughout the world, there have been many efforts carried out in different labs to invent such a drug and also identifying any pre-existing drugs which can carry out the killing of the virus. In this review, an effort has been made to understand the potential drugs which can be used against the SARS-CoV-2 viral infection. Again, the strategies on the current and the future drug discovery mechanisms against the SARS-CoV-2 are also mentioned. The different drugs made and the drugs re-used and also the drugs which are in the making process in different research laboratories across the world are also mentioned. To combat this unexpected crisis, we still need some more efforts from the different scientific communities around the world for finding a cure against this viral infection and this is needed to be done for the prevention of more loss of human life.

Keywords: COVID-19; Coronavirus; Drug; Drug repurposing; Drugs; Pandemic.

PubMed Disclaimer

Conflict of interest statement

The authors do not have any conflict of interest.

Figures

Fig. 1
Fig. 1
The most common symptoms of COVID-19 according to the WHO
Fig. 2
Fig. 2
The probable origin of the SARS-COV-2 virus
Fig. 3
Fig. 3
Hierarchical view of approaches for drug repurposing
See this image and copyright information in PMC

References

    1. Alexander R, Ravi A, Barclay H, Sawhney I, Chester V, Malcolm V, Brolly K, Mukherjee K, Zia A, Tharian R, Howell A, Lane T, Cooper V, Langdon PE. Guidance for the treatment and management of COVID-19 among people with intellectual disabilities. Journal of Policy and Practice in Intellectual Disabilities. 2020;17(3):256–269. doi: 10.1111/jppi.12352. - DOI - PMC - PubMed
    1. Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 among children in China. Pediatrics. 2020;145(6):e20200702. doi: 10.1542/peds.2020-0702. - DOI - PubMed
    1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, Li B, Huang CL, Chen HD, Chen J, Luo Y, Guo H, Jiang RD, Liu MQ, Chen Y, Shen XR, Wang X, Zheng XS, Zhao K, Chen QJ, Deng F, Liu LL, Yan B, Zhan FX, Wang YY, Xiao GF, Shi ZL. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270–273. doi: 10.1038/s41586-020-2012-7. - DOI - PMC - PubMed
    1. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ. COVID-19 Systematic Urgent Review Group Effort (SURGE) study authors. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–1987. doi: 10.1016/S0140-6736(20)31142-9. - DOI - PMC - PubMed
    1. Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, Queen K, Tao Y, Paden CR, Zhang J, Li Y, Uehara A, Wang H, Goldsmith C, Bullock HA, Wang L, Whitaker B, Lynch B, Gautam R, Schindewolf C, Lokugamage KG, Scharton D, Plante JA, Mirchandani D, Widen SG, Narayanan K, Makino S, Ksiazek TG, Plante KS, Weaver SC, Lindstrom S, Tong S, Menachery VD, Thornburg NJ. Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease United States. Emerging Infectious Diseases. 2020;26(6):1266–1273. doi: 10.3201/eid2606.200516. - DOI - PMC - PubMed

Substances

LinkOut - more resources